NCT05813158

Brief Summary

The aim of this study is to compare and evaluate the analgesic effects of ultrasound-guided Erector Spinae Plane block using low volumes and high concentrations versus high volumes and low concentrations in patients undergoing MRM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Sep 2022

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2022

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
Last Updated

May 3, 2023

Status Verified

April 1, 2023

Enrollment Period

3 months

First QC Date

November 18, 2022

Last Update Submit

April 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total dose of morphine needed postoperatively

    Total dose of morphine needed postoperatively

    Through Study Completion Up to 1 Day

Secondary Outcomes (6)

  • Time to first rescue analgesia, starting after extubation

    Through Study Completion over the first 24 hours postoperative

  • Duration of surgery

    Through Study Completion 24 hours postoperative

  • Blood loss,

    Through Study Completion,an average of 1day

  • Total dose of fentanyl required intraoperative (including induction dose)

    Through study completion,an average of 1day

  • Pain score at 15, 30, 45 and 60 min., 3,6,12 and 24 h after surgery

    through study completion,an average of 1day

  • +1 more secondary outcomes

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Patients will preoperatively receive low concentration-high volume U/S ESP block, and then the patient will be transferred to the operating room one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline}, for each patient.

Drug: Group 1(low concentration-high volume bupivacaine US guided Erector Spinae Plane block)

Group 2

ACTIVE COMPARATOR

Patients will preoperatively receive high concentration-low volume U/S ESP block block, and then the patient will be transferred to the operating room one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% }, for each patien).

Drug: Group 2(high concentration-low volumecbupivacaine US guided Erector Spinae Plane block)

Interventions

Patients will preoperatively receive low concentration-high volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline} for each patient

Also known as: Erector Spinae Plane Block with high volume-low concentration bupivacaine 0.25%
Group 1

Patients will preoperatively receive high concentration-low volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% } for each patien).

Also known as: Erector Spinae Plane Block with low volume-high concentration bupivacaine 0.25%
Group 2

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age starting from 18 to 60 years.
  • Genders eligible for study: female sex.
  • ASA II-III.
  • Patients undergoing modified radical mastectomy.
  • Body mass index (BMI) from 18.5 to 30 kg/m2.

You may not qualify if:

  • Patient refusal
  • Known allergy to local anesthetics
  • Bleeding disorders; platelets count \<50,000, prothrombin concentration \<60% or any coagulopathy disorder.
  • Use of any anti-coagulants
  • Inability to provide informed consent
  • ASA IV
  • Neurological disorders
  • Patient with psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdalla Mohamed

Cairo, 11451, Egypt

Location

Study Officials

  • Ahmed Abdalla Mohamed, M.D

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Patients will be randomly allocated to one of the two groups by sealed closed envelop technique
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: We hypothesize that high volume low concentration ultrasound-guided Erector Spinae Plane block is going to be more effective than low volume high concentration in patients undergoing MRM. Many authors advocate increasing the volume of injection in fascial plane blocks to allow better spread of local anesthetic according to multiple studies
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University

Study Record Dates

First Submitted

November 18, 2022

First Posted

April 14, 2023

Study Start

September 9, 2022

Primary Completion

December 16, 2022

Study Completion

December 23, 2022

Last Updated

May 3, 2023

Record last verified: 2023-04

Locations